Clarity Medical Systems Inc.
This article was originally published in Start Up
For all intents and purposes, ophthalmologists and optometrists are using the same screening and imaging technologies for diagnosing eye disorders that they have used for the past century. Clarity Medical Systems intends to disrupt the status quo with a single platform that physicians can use to screen, evaluate and one day potentially treat eye disease.
You may also be interested in...
The clinical community has long been searching for a safe and effective surgical alternative to drugs for glaucoma, but the field has moved slowly. A decade ago, non-invasive laser procedures began earning a place as a second-line therapy with limited durability. Invasive surgeries are reserved for end-stage glaucoma because of their complexity, their serious complications, and their high failure rates. Venture firms believe a large, unmet clinical need represents a new $1 billion device market, and the pace of glaucoma device company creation is picking up.
The Foundry has created a new incubator to focus on ophthalmology, Forsight Labs, in partnership with Eugene de Juan, MD, a leading ophthalmologist and serial entrepreneur, who was one of the founders of Second Sight, and InnoRx.
VCs have funded at least a dozen start-ups working in presbyopia, including C&C Vision, whose founder Stuart Cumming has been quietly working on an accomodating intraocular lens for more than ten years. With the FDA's Ophthalmic Devices Panel unanimously recommending premarket approval of C&C Vision's CrystaLens accommodating intraocular lens for cataract patients, his firm is very close to being able to reap a first-mover advantage in this new market.